• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

FibroGen grabs an option to buy cancer drug startup Fortis

cafead

Administrator
Staff member
  • cafead   May 09, 2023 at 11:32: PM
via FibroGen has licensed an experimental cancer drug from biotechnology startup Fortis Therapeutics and grabbed an option to acquire the smaller company at a later date.

article source